Arun Swaminath

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Use of video capsule endoscopy in Crohn's disease
    A Swaminath
    Department of Medicine, Columbia University Medical Center, New York, NY, USA
    Minerva Gastroenterol Dietol 56:437-49. 2010
  2. doi request reprint Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients
    A Swaminath
    Division of Digestive and Liver Diseases, Columbia University Presbyterian Hospital, New York, NY 10032, USA
    Aliment Pharmacol Ther 29:273-8. 2009
  3. doi request reprint Effect of physician education and patient counseling on inpatient nonsurgical percutaneous feeding tube placement rate, indications, and outcome
    Arun Swaminath
    Division of Gastroenterology, Columbia University Presbyterian Hospital, New York City, NY 10032, USA
    South Med J 103:126-30. 2010
  4. ncbi request reprint Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux
    Arun Swaminath
    Department of Medicine, Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York 10032, USA
    Inflamm Bowel Dis 16:1254-62. 2010
  5. doi request reprint Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts
    Arun Swaminath
    Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, 622 West 168th Street, PH 20 303, New York, NY 10032, USA
    Dig Dis Sci 56:1160-4. 2011
  6. doi request reprint Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab
    Arun Swaminath
    Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    J Clin Rheumatol 17:281-3. 2011
  7. doi request reprint Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease
    Ting Chin David Shen
    Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA
    J Clin Neuromuscul Dis 13:137-45. 2012
  8. ncbi request reprint Optimizing drug therapy in inflammatory bowel disease
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1069, New York, NY 10029, USA
    Curr Gastroenterol Rep 9:513-20. 2007
  9. pmc Microbial manipulation as primary therapy for Crohn's disease
    Randy S Longman
    Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    World J Gastroenterol 19:1513-6. 2013
  10. ncbi request reprint Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, NY, USA
    Inflamm Bowel Dis 14:213-6. 2008

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Use of video capsule endoscopy in Crohn's disease
    A Swaminath
    Department of Medicine, Columbia University Medical Center, New York, NY, USA
    Minerva Gastroenterol Dietol 56:437-49. 2010
    ..We will focus on comparative imaging data, how capsule endoscopy may aid in the prediction of disease type and course, the avoidance and meaning of capsule retention, along with cost considerations, and directions for the future...
  2. doi request reprint Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients
    A Swaminath
    Division of Digestive and Liver Diseases, Columbia University Presbyterian Hospital, New York, NY 10032, USA
    Aliment Pharmacol Ther 29:273-8. 2009
    ..Adalimumab, at an induction dose of 160/80 mg followed by 40 mg every other week is approved for treatment of refractory Crohn's disease (CD) and for patients with loss of response to infliximab...
  3. doi request reprint Effect of physician education and patient counseling on inpatient nonsurgical percutaneous feeding tube placement rate, indications, and outcome
    Arun Swaminath
    Division of Gastroenterology, Columbia University Presbyterian Hospital, New York City, NY 10032, USA
    South Med J 103:126-30. 2010
    ..We assessed the effect of physician education and counseling for patients and their surrogates on inpatient nonsurgical (endoscopic and radiologic) PFT placement rates, indications, complications, and mortality...
  4. ncbi request reprint Video capsule endoscopy in inflammatory bowel disease: past, present, and future redux
    Arun Swaminath
    Department of Medicine, Division of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York 10032, USA
    Inflamm Bowel Dis 16:1254-62. 2010
    ....
  5. doi request reprint Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts
    Arun Swaminath
    Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, 622 West 168th Street, PH 20 303, New York, NY 10032, USA
    Dig Dis Sci 56:1160-4. 2011
    ..There are no guidelines to clarify which of the drugs may be better suited to individual clinical scenarios...
  6. doi request reprint Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab
    Arun Swaminath
    Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    J Clin Rheumatol 17:281-3. 2011
    ..Treatment with anti-B-cell therapy may be a new treatment option for patients with gammopathy-associated leukocytoclastic vasculitis...
  7. doi request reprint Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease
    Ting Chin David Shen
    Department of Medicine, Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA
    J Clin Neuromuscul Dis 13:137-45. 2012
    ..An association between celiac disease (CD) and peripheral neuropathy (PN) has been reported...
  8. ncbi request reprint Optimizing drug therapy in inflammatory bowel disease
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, 1425 Madison Avenue, Box 1069, New York, NY 10029, USA
    Curr Gastroenterol Rep 9:513-20. 2007
    ..Lastly, additional information regarding the optimal method for using anti-tumor necrosis factor therapy continues to accumulate...
  9. pmc Microbial manipulation as primary therapy for Crohn's disease
    Randy S Longman
    Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    World J Gastroenterol 19:1513-6. 2013
    ..In this commentary, we discuss aspects of durability, immune cell polarization, and safety of microbial manipulation as primary therapy for CD...
  10. ncbi request reprint Dilation of colonic strictures by intralesional injection of infliximab in patients with Crohn's colitis
    Arun Swaminath
    Henry D Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, NY, USA
    Inflamm Bowel Dis 14:213-6. 2008
    ..Although the TREAT registry has shown systemic infliximab to be safe in the long term, there is concern regarding infectious as well as neoplastic complications...
  11. pmc Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease
    Arun Swaminath
    Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York Department of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts and Mailman School of Public Health, Columbia University, New York, New York
    Inflamm Bowel Dis 19:2444-9. 2013
    ..We compared the performance of TST and QFT-G for screening latent TB among immunosuppressed IBD patients based on prevalence, mortality risk from reactivation TB, and costs...